Literature DB >> 19392924

Impact of COPD severity on physical disability and daily living activities: EDIP-EPOC I and EDIP-EPOC II studies.

J M Rodriguez Gonzalez-Moro1, P de Lucas Ramos, J L Izquierdo Alonso, B López-Muñiz Ballesteros, E Antón Díaz, X Ribera, A Martín.   

Abstract

AIMS: The severity of chronic obstructive pulmonary disease (COPD) is associated to patients' health-related quality of life (HRQL). Physical impairment increasingly affects daily activities creating economic, social and personal burden for patients and their families. This burden should be considered in the management of COPD patients; therefore, we intended to assess the impact of the disease severity on physical disability and daily activities.
METHODS: Two epidemiological observational cross-sectional descriptive studies were carried out in 1596 patients with moderate COPD and 2012 patients with severe or very severe COPD in the routine clinical practice. Demographic and basic clinical-epidemiological data were collected and patients completed questionnaires to assess their physical disability because of COPD [Medical Research Council (MRC)], COPD repercussion on daily activities [London Chest Activity of Daily Living (LCADL)], job, economy and family habits and their health status [EQ-5D visual analogue scale (VAS)].
RESULTS: In all, 37% of severe/very severe COPD patients and 10% of moderate (p < 0.0001) had MRC grades 4 and 5. Mean global LCADL was significantly higher in severe/very severe than in moderate patients [29.6 (CI 95%: 28.91-30.25) vs. 21.4 (CI 95%: 20.8-21.9); p < 0.0001]. COPD job impact and economic and family habits repercussions were significantly higher and health status significantly worse in severe/very severe cases than in patients with moderate COPD.
CONCLUSIONS: COPD severity is highly associated with physical disability by MRC grading, with functionality on daily activities and with impairment of other social and clinical activities. Moderate COPD patients show already a significant degree of impairment in all these parameters.

Entities:  

Mesh:

Year:  2009        PMID: 19392924     DOI: 10.1111/j.1742-1241.2009.02040.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  15 in total

1.  Both pulmonary and extra-pulmonary factors predict the development of disability in chronic obstructive pulmonary disease.

Authors:  Jonathan P Singer; Patricia P Katz; Carlos Iribarren; Theodore A Omachi; Gabriela Sanchez; Edward H Yelin; Miriam G Cisternas; Paul D Blanc
Journal:  Respiration       Date:  2012-06-09       Impact factor: 3.580

2.  Effects of depression diagnosis and antidepressant treatment on mortality in Medicare beneficiaries with chronic obstructive pulmonary disease.

Authors:  Jingjing Qian; Linda Simoni-Wastila; Patricia Langenberg; Gail B Rattinger; Ilene H Zuckerman; Susan Lehmann; Michael Terrin
Journal:  J Am Geriatr Soc       Date:  2013-04-25       Impact factor: 5.562

3.  COPD and cognitive impairment: the role of hypoxemia and oxygen therapy.

Authors:  Neeta Thakur; Paul D Blanc; Laura J Julian; Edward H Yelin; Patricia P Katz; Stephen Sidney; Carlos Iribarren; Mark D Eisner
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-09-07

4.  Depression in individuals with chronic obstructive pulmonary disease and their informal caregivers.

Authors:  Hoda Badr; Alex D Federman; Michael Wolf; Tracey A Revenson; Juan P Wisnivesky
Journal:  Aging Ment Health       Date:  2016-05-20       Impact factor: 3.658

5.  Disability related to COPD tool (DIRECT): towards an assessment of COPD-related disability in routine practice.

Authors:  B Aguilaniu; J Gonzalez-Bermejo; A Regnault; C Dias Barbosa; B Arnould; M Mueser; G Granet; M Bonnefoy; T Similowski
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-07-05

6.  Economic burden of chronic bronchitis in the United States: a retrospective case-control study.

Authors:  Christopher M Blanchette; Melissa H Roberts; Hans Petersen; Anand A Dalal; Douglas W Mapel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-01-13

7.  Efficacy of lovastatin on learning and memory deficits caused by chronic intermittent hypoxia-hypercapnia: through regulation of NR2B-containing NMDA receptor-ERK pathway.

Authors:  Xin-long Huo; Jing-jing Min; Cai-yu Pan; Cui-cui Zhao; Lu-lu Pan; Fei-fei Gui; Lu Jin; Xiao-tong Wang
Journal:  PLoS One       Date:  2014-04-09       Impact factor: 3.240

8.  Functional outcomes in patients with chronic obstructive pulmonary disease: a multivariate analysis.

Authors:  Filipe T S Athayde; Danielle S R Vieira; Raquel R Britto; Verônica F Parreira
Journal:  Braz J Phys Ther       Date:  2014 Jan-Feb       Impact factor: 3.377

9.  Physical inactivity in COPD and increased patient perception of dyspnea.

Authors:  Milla Katajisto; Henna Kupiainen; Piritta Rantanen; Ari Lindqvist; Maritta Kilpeläinen; Heikki Tikkanen; Tarja Laitinen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-10-29

10.  Daily Activities: The Impact of COPD and Cognitive Dysfunction.

Authors:  Amanda M Brunette; Kelsey Warner; Kristen E Holm; Kimberly Meschede; Frederick S Wamboldt; Elizabeth Kozora; David J Moser; Barry J Make; James D Crapo; Kerrie L Moreau; Howard D Weinberger; Russell Bowler; Karin F Hoth
Journal:  Arch Clin Neuropsychol       Date:  2021-07-19       Impact factor: 2.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.